Advancements in the Application of Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs)

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2024 Apr 27

PMID 38672495

Authors

Sang-Woo Han

Hyung-Sik Won

Affiliations

Soon will be listed here.

Abstract

Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a significant potential for novel therapeutic applications because of their bioactive properties, stability, and specificity. RiPPs are synthesized on ribosomes, followed by intricate post-translational modifications (PTMs), crucial for their diverse structures and functions. PTMs, such as cyclization, methylation, and proteolysis, play crucial roles in enhancing RiPP stability and bioactivity. Advances in synthetic biology and bioinformatics have significantly advanced the field, introducing new methods for RiPP production and engineering. These methods encompass strategies for heterologous expression, genetic refactoring, and exploiting the substrate tolerance of tailoring enzymes to create novel RiPP analogs with improved or entirely new functions. Furthermore, the introduction and implementation of cutting-edge screening methods, including mRNA display, surface display, and two-hybrid systems, have expedited the identification of RiPPs with significant pharmaceutical potential. This comprehensive review not only discusses the current advancements in RiPP research but also the promising opportunities that leveraging these bioactive peptides for therapeutic applications presents, illustrating the synergy between traditional biochemistry and contemporary synthetic biology and genetic engineering approaches.

Citing Articles

Integrating Metabolomics and Genomics to Uncover Antimicrobial Compounds in UTNGt2, a Cacao-Originating Probiotic from Ecuador.

Molina D, Angamarca E, Marinescu G, Popescu R, Tenea G Antibiotics (Basel). 2025; 14(2).

PMID: 40001367 PMC: 11851819. DOI: 10.3390/antibiotics14020123.

Characterization and Probiotic Potential of DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming .

Iliev I, Yahubyan G, Apostolova-Kuzova E, Gozmanova M, Mollova D, Iliev I Microorganisms. 2025; 13(1).

PMID: 39858927 PMC: 11767307. DOI: 10.3390/microorganisms13010160.

Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions.

Hwang H, Nam Y, Jang C, Kim E, Jang E, Lee Y Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852121 PMC: 11764418. DOI: 10.3390/cimb47010006.

References

Havarstein L, Diep D, Nes I . A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol Microbiol. 1995; 16(2):229-40. DOI: 10.1111/j.1365-2958.1995.tb02295.x. View

Frattaruolo L, Lacret R, Cappello A, Truman A . A Genomics-Based Approach Identifies a Thioviridamide-Like Compound with Selective Anticancer Activity. ACS Chem Biol. 2017; 12(11):2815-2822. DOI: 10.1021/acschembio.7b00677. View

Santos-Aberturas J, Chandra G, Frattaruolo L, Lacret R, Pham T, Vior N . Uncovering the unexplored diversity of thioamidated ribosomal peptides in Actinobacteria using the RiPPER genome mining tool. Nucleic Acids Res. 2019; 47(9):4624-4637. PMC: 6511847. DOI: 10.1093/nar/gkz192. View

He B, Cheng Z, Zhong Z, Gao Y, Liu H, Li Y . Expanded Sequence Space of Radical S-Adenosylmethionine-Dependent Enzymes Involved in Post-translational Macrocyclization. Angew Chem Int Ed Engl. 2022; 61(48):e202212447. DOI: 10.1002/anie.202212447. View

Wang H, Li Z, Jia R, Yin J, Li A, Xia L . ExoCET: exonuclease in vitro assembly combined with RecET recombination for highly efficient direct DNA cloning from complex genomes. Nucleic Acids Res. 2017; 46(5):e28. PMC: 5861427. DOI: 10.1093/nar/gkx1249. View

Rucker E, Schneider G, Steinhauser K, Lower R, HAUBER J, Stauber R . Rapid evaluation and optimization of recombinant protein production using GFP tagging. Protein Expr Purif. 2001; 21(1):220-3. DOI: 10.1006/prep.2000.1373. View

Oman T, Knerr P, Bindman N, Velasquez J, van der Donk W . An engineered lantibiotic synthetase that does not require a leader peptide on its substrate. J Am Chem Soc. 2012; 134(16):6952-5. PMC: 3350211. DOI: 10.1021/ja3017297. View

Cwirla S, Peters E, Barrett R, Dower W . Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci U S A. 1990; 87(16):6378-82. PMC: 54537. DOI: 10.1073/pnas.87.16.6378. View

Precord T, Mahanta N, Mitchell D . Reconstitution and Substrate Specificity of the Thioether-Forming Radical -Adenosylmethionine Enzyme in Freyrasin Biosynthesis. ACS Chem Biol. 2019; 14(9):1981-1989. PMC: 7362900. DOI: 10.1021/acschembio.9b00457. View

10.

Guo L, Stoffels K, Broos J, Kuipers O . Engineering hybrid lantibiotics yields the highly stable and bacteriocidal peptide cerocin V. Microbiol Res. 2024; 282:127640. DOI: 10.1016/j.micres.2024.127640. View

11.

Zhang Q, Yu Y, Velasquez J, van der Donk W . Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A. 2012; 109(45):18361-6. PMC: 3494888. DOI: 10.1073/pnas.1210393109. View

12.

Wang G . Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering. Curr Biotechnol. 2014; 1(1):72-79. PMC: 3914544. DOI: 10.2174/2211550111201010072. View

13.

Bratkovic T . Progress in phage display: evolution of the technique and its application. Cell Mol Life Sci. 2010; 67(5):749-67. PMC: 11115567. DOI: 10.1007/s00018-009-0192-2. View

14.

Thibodeaux C . The conformationally dynamic structural biology of lanthipeptide biosynthesis. Curr Opin Struct Biol. 2023; 81:102644. DOI: 10.1016/j.sbi.2023.102644. View

15.

Acedo J, Bothwell I, An L, Trouth A, Frazier C, van der Donk W . -Methyltransferase-Mediated Incorporation of a β-Amino Acid in Lanthipeptides. J Am Chem Soc. 2019; 141(42):16790-16801. PMC: 6812601. DOI: 10.1021/jacs.9b07396. View

16.

Cao L, Do T, Zhu A, Duan J, Alam N, Link A . Genome Mining and Discovery of Imiditides, a Family of RiPPs with a Class-Defining Aspartimide Modification. J Am Chem Soc. 2023; 145(34):18834-18845. PMC: 10947588. DOI: 10.1021/jacs.3c03991. View

17.

Sun Z, Xia Z, Bi F, Liu J . Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli. Appl Microbiol Biotechnol. 2008; 78(3):495-502. DOI: 10.1007/s00253-007-1330-0. View

18.

Franz L, Koehnke J . Leader peptide exchange to produce hybrid, new-to-nature ribosomal natural products. Chem Commun (Camb). 2021; 57(52):6372-6375. DOI: 10.1039/d0cc06889f. View

19.

Sarkar S, Gu W, Schmidt E . Applying Promiscuous RiPP Enzymes to Peptide Backbone -Methylation Chemistry. ACS Chem Biol. 2022; 17(8):2165-2178. PMC: 9526446. DOI: 10.1021/acschembio.2c00293. View

20.

Si T, Tian Q, Min Y, Zhang L, Sweedler J, van der Donk W . Rapid Screening of Lanthipeptide Analogs via In-Colony Removal of Leader Peptides in Escherichia coli. J Am Chem Soc. 2018; 140(38):11884-11888. PMC: 6476326. DOI: 10.1021/jacs.8b05544. View